Susana Torres-Martínez

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Peritoneal Dialysis

Bioinformatics Analysis

Epidermal Growth Factor Receptor

Ejection Fraction

Top Venues

International journal of molecular sciences

Molecular oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Susana Torres-Martínez, Silvia Calabuig-Fariñas, Andrea Moreno-Manuel, Giulia Bertolini, Alejandro Herreros-Pomares, Eva Escorihuela, Elena Duréndez-Sáez, Ricardo Guijarro, Ana Blasco, Luca Roz, Carlos Camps, Eloísa Jantus-Lewintre
Soluble galectin-3 as a microenvironment-relevant immunoregulator with prognostic and predictive value in lung adenocarcinoma. Molecular oncology (2023)
Susana Torres-Martínez, Silvia Calabuig-Fariñas, Sandra Gallach, Marais Mosqueda, Ester Munera-Maravilla, Rafael Sirera, Lara Navarro, Ana Blasco, Carlos Camps, Eloísa Jantus-Lewintre
Circulating Immune Proteins: Improving the Diagnosis and Clinical Outcome in Advanced Non-Small Cell Lung Cancer. International journal of molecular sciences 24 (24) (2023)
Susana Torres-Martínez, Silvia Calabuig-Fariñas, Sandra Gallach, Marais Mosqueda, Ester Munera-Maravilla, Rafael Sirera, Lara Navarro, Ana Blasco, Carlos Camps, Eloísa Jantus-Lewintre
Circulating Immune Proteins: Improving the Diagnosis and Clinical Outcome in Advanced Non-Small Cell Lung Cancer. International journal of molecular sciences 24 (24) (2023)
Elena Duréndez-Sáez, Silvia Calabuig-Fariñas, Susana Torres-Martínez, Andrea Moreno-Manuel, Alejandro Herreros-Pomares, Eva Escorihuela, Marais Mosqueda, Sandra Gallach, Ricardo Guijarro, Eva Serna, Cristian Suárez-Cabrera, Jesus M Paramio, Ana Blasco, Carlos Camps, Eloísa Jantus-Lewintre
Analysis of Exosomal Cargo Provides Accurate Clinical, Histologic and Mutational Information in Non-Small Cell Lung Cancer. Cancers 14 (13) (2022)
Martín Núñez Abad, Silvia Calabuig-Fariñas, Miriam Lobo de Mena, Susana Torres-Martínez, Clara García González, José Ángel García-García, Vega Iranzo González-Cruz, Carlos Camps
Programmed Death-Ligand 1 (PD-L1) as Immunotherapy Biomarker in Breast Cancer. Cancers 14 (2) (2022)